#Prenatal and New-born Genetic Testing Market Trends

[mitalipingale]

The Prenatal and New-born Genetic Testing Market in 2023 is US$ 6.1 billion, and is expected to reach US$ 14.81 billion by 2031 at a CAGR of 11.7%.

[industrynewsupdates]

Understanding Preimplantation Genetic Testing Market: Trends and Insights

The global preimplantation genetic testing (PGT) market was estimated to be valued at USD 802.2 million in 2023, with projections indicating a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. This growth is largely driven by the increasing prevalence of single-gene, mitochondrial, and other genetic disorders, which is anticipated to elevate the demand for preimplantation diagnostic and screening processes in the upcoming years. According to the Florida Department of Health, around one in every 33 babies born in the U.S. is affected by a congenital disability, resulting in nearly 120,000 affected infants annually. As new testing options are introduced, demand for these services is expected to rise. For instance, in July 2023, Thermo Fisher Scientific Inc. launched two next-generation sequencing (NGS)-based tests specifically designed for preimplantation genetic testing for aneuploidy (PGT-A).

The integration of aneuploidy screening in preimplantation genetic diagnosis (PGD) has significantly enhanced in vitro fertilization (IVF) procedures. By utilizing aneuploidy testing in IVF centers, healthcare providers can identify embryos with chromosomal abnormalities, which leads to improved pregnancy success rates. Preimplantation genetic testing for aneuploidy (PGT-A) assesses embryos for chromosomal integrity, ensuring they possess the correct number of chromosomes. The benefits of PGT-A—such as higher chances of pregnancy, lower miscarriage rates, and fewer IVF cycles required to achieve a successful pregnancy—are expected to further stimulate the adoption of these tests in the forecast period.

Gather more insights about the market drivers, restrains and growth of the Preimplantation Genetic Testing Market

Industry Dynamics

The preimplantation genetic testing market has experienced considerable innovation, marked by advancements like PGT-A and PGT-M. These developments enhance diagnostic accuracy, mitigate risks, and improve pregnancy success rates, which collectively drive market expansion and deliver better outcomes for individuals dealing with genetic and fertility challenges.

The market landscape is characterized by key players who engage in moderate levels of product launches and merger and acquisition (M&A) activities. Companies are increasingly consolidating their resources to harness advanced technologies, broaden their market presence, and enhance their service offerings. This trend is instrumental in fostering growth and innovation within the sector, ultimately improving outcomes for patients seeking genetic and fertility solutions.

Regulatory frameworks play a significant role in shaping the preimplantation genetic testing market, ensuring that safety, efficacy, and ethical standards are maintained. Stringent regulations govern the development and implementation of testing procedures, thereby building trust among patients and healthcare practitioners. However, the complexity of these regulations can also present challenges for market entry and innovation, potentially affecting the speed of technological advancements.

In terms of alternatives, the preimplantation genetic testing market faces competition from traditional prenatal diagnostic methods, such as amniocentesis and chorionic villus sampling (CVS). Unlike PGT, these conventional methods assess genetic disorders only after pregnancy has been established, which can lead to difficult choices if abnormalities are detected. While these alternatives provide diagnostic options, they do not offer the early intervention advantages that PGT presents.

Order a free sample PDF of the Preimplantation Genetic Testing Market Intelligence Study, published by Grand View Research.

[aartichede08]

North America Genetic Testing Market Insights, Trends, And Forecasts 2019-2028

Primarily the genetic testing is a simple process in which our DNA is collected and runs through the bloodlines of all living beings is extracted and put under through examination. Through this, changes in the structure of chromosomes are identified and it is simpler to predict the kind of diseases a person has contracted. Genetic testing is also useful in prediction of level of susceptibility that a person has towards diseases in order for prevent it from materializing. According to the world health organization, around 10,000 diseases in the world are monogenetic. Which is caused due to modification or mutation in a single gene present in every single cell of the body.

To know the scope of our report get a sample on https://www.axiommrc.com/request-for-sample/10898-north-america-genetic-testing-market-report

MARKET DYNAMICS- NORTH AMERICA GENETIC TESTING MARKET

The North America genetic testing market is witnessing lucrative growth during forecast period of 2021 to 2027. According to world health organization, 9.6 million deaths occurred worldwide due to cancer in the year 2018. These statistics are alarming as this disease is on all time affecting the entire world and is a borderline epidemic. The rising incidence of genetic disorders is propelling growth of North America genetic testing market. The growing awareness and acceptance of personalized medicines is also boosting growth of North America genetic testing market. However, social and ethical implication of genetic testing is hampering growth of North America genetic testing market.

 

COVID-19 IMPACT ON NORTH AMERICA GENETIC TESTING MARKET

The exclusive COVID-19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the genetic testing market. In addition, complete analysis of changes on genetic testing expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on North America economies, international trade, business investments, GDP and marketing strategies of key players present in the market. The COVID-19 has almost affected every market is healthcare industries positively or negatively. The genetic testing market is got hampered in somewhat manner as the COVID-10 is declared as global pandemic by World Health Organization and in various countries there is complete shutdown and guidelines regarding the social distancing are applied for prevention against the COVID-19 pandemic. Additionally, clinics are operating at limited capacities and reduced face to face genetic counselling for preventing against the COVID-19 viruses. Thus, the COVID-19 pandemic have the negative impact on the genetic testing market.

NORTH AMERICA GENETIC TESTING MARKET- SEGMENTAL OVERVIEW

The North America genetic testing market is bifurcated by type, technology, application and country.

 

NORTH AMERICA GENETIC TESTING MARKET BY TYPE

Various type of genetic testing such as predictive & presymptomatic testing, carrier testing, prenatal & new born testing, diagnostic testing, pharmacogenomic testing and others are comprised in the North America genetic testing market. In which carrier testing is also contributing to the growth of North America genetic testing market. The carrier testing is a type of genetic testing which is used for determination of the person is a carrier for specific autosomal recessive diseases. It is used commonly by couples who are considering becoming pregnant to determine the risk of their child inheriting one of the genetic disorders.

 

NORTH AMERICA GENETIC TESTING MARKET BY TECHNOLOGY

Various technologies such as cytogenetic testing, biochemical testing and molecular testing are comprised in the North America genetic testing market. In which cytogenetic testing is also contributing to the growth of North America genetic testing market. Cytogenetic testing included the evaluation of samples of tissue, blood or bone marrow in a laboratory for examining changes in chromosomes which comprises the broken, missing, rearranged or extra chromosome. The changes in certain chromosomes is a sign of genetic disease or conditions or some type of cancers.

 

NORTH AMERICA GENETIC TESTING MARKET BY APPLICATION

Various applications of genetic testing such as alzheimer’s disease, cancer, cystic fibrosis, sickle cell anaemia, duchenne muscular dystrophy, thalassemia, huntington’s disease, rare diseases and other are comprised in the North America genetic testing market. The alzheimer’s diseases diagnosis is also contributing to the growth of North America genetic testing market. The alzheimer’s diseases is a progressive neurological disorder which cause the brain to shrink and brain cells to die. Alzheimer’s diseases is the most common cause of dementia which is a continuos decline in thinking, behavioural and social skills that affects a person’s ability to function independently.

 

NORTH AMERICA GENETIC TESTING MARKET BY COUNTRY

The North America genetic testing market is studied for key countries such as United States, Mexico and Canada. In which United States is anticipated to dominate the market in 2020. The rising incidences of genetic disorders is propelling growth of North America genetic testing market. The growing cases of cancers is also boosting growth of North America genetic testing market. The rising research and development activities is also driving growth of North America genetic testing market.

 

KEY PLAYERS IN GENETIC TESTING MARKET

The major key player covered in the report are 23 & Me Inc., Abbott Laboratories, Myriad Genetics Inc., Danaher Corporation, Illumina Inc., Luminex Corporation, Biorad Laboratories Inc., Perkinelmer Inc., Quest Diagnostics Incorporated, F. Hoffmann-La Roche Ltd, Eurofins Scientific and Qiagen Nv among others.

 

KEY DEVELOPMENTS IN GENETIC TESTING MARKET

November 2020: The FDA expanded the approval of cancer blood test, “Liquid Biopsy” which detects the genetic changes in tumour DNA in the blood and may help match patients for potential treatment.

 

August 2020: FDA approved the Guradant 360 CDx of Guardant health and foundation, it is the one liquid CDx of foundation medicine, which is used as a companion diagnostic test and general tumour profiling.

 

January 2020: The Quest Diagnostic, a US based clinical laboratory announced Finnish genetic testing company blueprint genetics for rising next generation sequencing capabilities for rare diseases.

 

May 2019: The Abbott laboratories announced the pre-approval of WHO for worlds first point of care viral load test, m-PIMA HIV-1/ 2 VL. The Abbott Laboratories have main products are comprised of the chromosome enumeration probes, FISH accessories and prenatal.

Buy now North America Genetic Testing Market Report https://www.axiommrc.com/buy_now/10898-north-america-genetic-testing-market-report

About Us:

Axiom Market Research & Consulting™ is a full-service market research and data analytics company providing key market intelligence to global companies to take informed business decisions pertaining to their marketing strategy, investments, new product launches, market competition, consumer or end users, social media trends etc. 

Axiom Market Research & Consulting™ offers market research services such as syndicated market research, custom market research, business consulting, and consumer/end user surveys. Under Business to Consumer (B2C) market research offerings, Axiom MRC assists its clients in finding quantitative information/preferences of its brands and services such as, awareness, usages, satisfaction, tracking, ethnicity etc. Axiom MRC offers data collection services through online surveys, social media, data processing and interpretation.

Axiom MRC with its experienced team of research and data analysts, has delivered more than 5000+ Market Research Projects, 3800+ Data Analytics Projects, 1200+ Business Support Projects and has a 800+ Global Client Base. Axiom Market Research & Consulting™ aims to become the preferred market research and data analytics company by providing key market intelligence solutions for client’s business growth.

Contact Us:

Axiom Market Research & Consulting™

3 Germay Dr. Ste 4 - 4666

Wilmington DE 19804

U.S.:- + 1 (845) 875-9786

U.K.:- + 44 (0) 20 3286 9707

Email: sales@axiommrc.com

Website: https://www.axiommrc.com/

Blog: https://industrywatch24.com/

Follow On

LinkedIn: https://www.linkedin.com/company/axiom-market-research-and-consulting/

Twitter:  https://twitter.com/AxiommrcCom

[pranalipawarshinde]

Genetic Testing Services Market Size, Growth, Trends and Forecast Report 2019-2027

Genetic Testing Services Market:Overview

Transparency Market Research (TMR) has published a new report titled, ‘Genetic Testing Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.According to the report, the global Genetic Testing Services market was valued at US$ 41.2 Bn in 2018 and is projected to expand at a CAGR of 7.3% from 2019 to 2027.

Overview

Genetic Testing is a medical test also known as DNA testing which determine changes in the chromosomes, genes, and proteins. This testing can suspect or rule out the suspected genetic conditions which determine any genetic disorder or diseases in the patients.

Various genetic testing available in the market are molecular genetic tests, chromosome genetic tests, and biochemical genetic tests. These tests study the single genes, whole chromosomes, and identify the abnormalities or activity level of the proteins.

Genetic testing would help in diagnosing diseases, severity of the disease, diagnosis  or identifying the changes in the genes, inherited risk of developing the diseases, and also enables the patient and physicians for establishing  the optimum treatment.

Report Overview: https://www.transparencymarketresearch.com/genetic-testing-services-market.html

New Born Screening Segment to Dominate Global Genetic Testing Services Market

In terms of test type, the global genetic testing services market has been segmented into prenatal testing, newborn screening, predictive & presymptomatic testing, pharmacogenomic testing, and others.

 New Born Screening segment likely to grow at highest growth care during forecast period. Rise in neonatal diseases, and increasing pediatric patients suffering from diseases are propelling factor for the segment growth in coming years.

Predictive and Presymptomatic Testing is another segment likely to held major market share in genetic testing services market. Genetic mutation leading to the development of various chronic diseases boosting the need of genetic testing services market during forecast period.

Oncology Segment Hold a Major Share of Global Genetic Testing Services Market

In terms of application, the global genetic testing services market has been classified into oncology, infectious diseases, autoimmune diseases and others. Oncology segment dominated the market in 2018 and it would continue its dominance during the forecast period.

Attributable factors driving the segment growth ascribed to the rising incidences of breast cancer, colorectal cancer, lung cancer and other types across globe. Moreover, early diagnosis of the cancer through genetic testing is another driving factor for the segment growth in coming years. Predictive test of breast cancer is another propelling factor for the segment growth during forecast period.

Request A Sample: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=10235

Hospitals based laboratories Segment to Dominate Global Genetic Testing Services Market

Based on service providers, the global genetic testing services market has been segmented into hospitals based laboratories, diagnostic laboratories, speciality clinics, and others. Hospitals based laboratories segment accounted for major share of the market. Rising incidence of diseases, increasing hospital stays, and growing geriatric population are few major factors expected to boost the segment during the forecast period. Moreover, long-term care of patients suffering from chronic diseases required expertise and standard diagnosis process likely to accelerate the hospital based laboratories segment during forecast period.

Speciality clinics to grow at rapid growth care during forecast period, owing to increasing investments and extensive R&D activities and wide outsourcing of a few specialty tests are factors fueling the speciality clinics segment.

North America to Dominate Global Genetic Testing Services Market

In terms of region, the global genetic testing services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global genetic testing services market in 2018, followed by Europe.

Request for covid19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=10235

North America accounted for major share of the global genetic testing services market in 2018. Technological advancements, presence of key players, launching of novel products, demand of diagnostics for cancer detection, rising prevalence and incidences of autoimmune, infectious diseases in the region are attributable factors for the market growth of the region.

The Genetic Testing Services market in Asia Pacific is anticipated to expand at a highest growth rate from 2019 to 2027. Increasing patient burden suffering from chronic diseases, and recent merger & acquisitions amongst key players offering genetic testing and services are estimated to propel the market in the Asia-Pacific region during forecast period.

Competitive Landscape

The global genetic testing services market is consolidated in terms of number of players. Key players in the global Genetic Testing Services market include Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Genomic Health, Inc., NeoGenomics Laboratories, Inc, Eurofins Scientific,  Ambry Genetics, Illumina, Inc, 23andMe, Inc., Exact Sciences, Natera, Invitae, Veracyte, and other prominent players.

More Trending Reports by Transparency Market Research:

Transplant Drug Monitoring Assay Market: https://www.transparencymarketresearch.com/transplant-drug-monitoring-assay-market.html

PRP and PRF in Cosmetics Market: https://www.transparencymarketresearch.com/prp-and-prf-in-cosmetics-market.html

Fetal Bovine Serum Market: https://www.transparencymarketresearch.com/fetal-bovine-serum-market.html

Cell Culture Market: https://www.transparencymarketresearch.com/cell-culture-market.html

Mice Model Market: https://www.transparencymarketresearch.com/mice-model-market.html

Molecular Diagnostics Market: https://www.transparencymarketresearch.com/molecular-diagnostics-industry.html

Human Microbiome Market: https://www.transparencymarketresearch.com/human-microbiome-market.html

Contraceptives Market: https://www.transparencymarketresearch.com/contraceptives-market.html

About Us

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.

Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.

For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update - https://www.youtube.com/channel/UC8e-z-g23-TdDMuODiL8BKQ

Contact

Rohit Bhisey Transparency Market Research Inc. CORPORATE HEADQUARTER DOWNTOWN, 1000 N. West Street, Suite 1200, Wilmington, Delaware 19801 USA Tel: +1-518-618-1030 USA – Canada Toll Free: 866-552-3453 Website: https://www.transparencymarketresearch.com Blog: https://tmrblog.com Email: sales@transparencymarketresearch.com

[chitrakullkarni]

DNA Testing/Diagnostics Market Prominent Players, Recent Developments and Trend Analysis

The global DNA Testing/Diagnostics Market research report provides complete insights on industry scope, trends, regional estimates, key application, competitive landscape and financial performance of prominent players. It also offers ready data-driven answers to several industry-level questions. This study enables numerous opportunities for the market players to invest in research and development.

Market Overview:

The global DNA Testing/Diagnostics Market is anticipated to grow at a staggering CAGR in the forthcoming period. Diagnostic tests are the basis of a successful healthcare system that enables vital information about patients and healthcare providers necessary to land into right decisions.

Key Players:

454 Life Sciences

Abbott Laboratories

Affymetrix Inc.

Agilent Technologies Inc.

Applied Biosystems Group

Thermo Fisher Scientific Inc.

Illumina

Cepheid

Hologic

Bio-Rad Laboratories

Dako

Alere

Roche Diagnostics

Request free sample to get a complete analysis of top-performing companies @ https://www.millioninsights.com/industry-reports/dna-testing-diagnostics-market/request-sample

Growth Drivers:

The drivers for DNA testing market include demand for personalized medicine applications for chronic disorders is likely to propel the market growth. Rise in demand for DNA diagnostics for new born babies adds to the market growth during the forecast period. In addition, genetic testing gains a higher traction to determine patient’s health at different stages of disease development fuels the market growth.

Technology Outlook:

Microarrays based diagnostics

PCR based diagnostics

In-situ hybridization diagnostics

NGS DNA diagnosis

Application Outlook:

Prenatal DNA Carrier Screening

Preimplantation Diagnosis

Newborn Genetic Screening

Infectious Disease DiagnosticsHBV Diagnostic HCV Diagnostic HIV Diagnostic TB Diagnostic CT/NG Diagnostic HPV Diagnostic MRSA Diagnostic

Oncology Diagnostics & Histopathology

Identity Diagnostics & Forensics

Pharmacogenomics Diagnostic Testing

Drug Metabolism & P450 effects

Regional Outlook:

Myogenic disorder is further segmented as pre-implantation diagnostics and prenatal diagnostics. Geographical segmentation for DNA testing market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America holds a dominant share in the global market owing to rise in adoption of DNA diagnostics technology and significant prevalence of chronic and infectious disease.

Asia-Pacific market is anticipated to rise at a higher CAGR due to rise in research programs conducted by government in developing economies. Constant R&D and commercialization of technology for treatment of chronic diseases is likely to contribute to the market growth during the forecast period. The key players in the DNA diagnostics industry include Cephide Inc., 454 Life Sciences, Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Hologic, GE Healthcare, Thermo Fisher Scientific, Illumina Inc., TransgenomicInc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, AlereInc, Affymetrix Inc., Agilent Technologies Inc., Dako, and Applied Biosystems Group.

Browse Related Category Research Reports @ https://industryanalysisandnews.wordpress.com/

[marketresearchtrendsblog]

Genetic Testing Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

The report on the global genetic testing market provides qualitative and quantitative analysis for the period from 2017 to 2025. The report predicts the global genetic testing market to grow with a CAGR of 11.5% over the forecast period from 2019-2025. The study on genetic testing market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025. The report on genetic testing market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global genetic testing market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Request to Fill The Form To get Sample Copy of This Report: https://www.sdki.jp/sample-request-103777 Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global genetic testing market over the period of 2017 to 2025. Further, IGR- Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider. Report Findings 1) Drivers • Rising prevalence of genetic and neurological disorders • Growing demand for new and effective techniques of diagnosing and treatment of genetic diseases 2) Restraints • High cost associated with molecular instruments • Limited availability of trained professionals 3) Opportunities • Increasing government funding for research and development Research Methodology A) Primary Research Our primary research involves extensive interviews and analysis of the opinions provided by the primary respondents. The primary research starts with identifying and approaching the primary respondents, the primary respondents are approached include 1. Key Opinion Leaders associated with Infinium Global Research 2. Internal and External subject matter experts 3. Professionals and participants from the industry Our primary research respondents typically include 1. Executives working with leading companies in the market under review 2. Product/brand/marketing managers 3. CXO level executives 4. Regional/zonal/ country managers 5. Vice President level executives. B) Secondary Research Secondary research involves extensive exploring through the secondary sources of information available in both the public domain and paid sources. At Infinium Global Research, each research study is based on over 500 hours of secondary research accompanied by primary research. The information obtained through the secondary sources is validated through the crosscheck on various data sources. The secondary sources of the data typically include 1. Company reports and publications 2. Government/institutional publications 3. Trade and associations journals 4. Databases such as WTO, OECD, World Bank, and among others. 5. Websites and publications by research agencies Segment Covered The global genetic testing market is segmented on the basis of type, application, and technology. The Global Genetic Testing Market by Type • Diagnostic Testing • Presymptomatic And Predictive Testing • Carrier Testing • Pharmacogenomics • Prenatal Testing • New Born Screening • Preimplantation Testing The Global Genetic Testing Market by Technology • PCR • DNA Sequencing • Cytogenetics • Microarrays • Gene Expression Profiling The Global Genetic Testing Market by Application • Chronic Diseases • Neurodegenerative Diseases • Cancer • Genetic Disorders • Autoimmune Disorders Company Profiles The companies covered in the report include • Thermo Fisher Scientific Inc. • QIAGEN • Bio-Rad Laboratories, Inc. • Becton, Dickinson and Company • F. Hoffmann-La Roche AG • Macrogen, Inc. • Agilent Technologies, Inc. What does this report deliver? 1. Comprehensive analysis of the global as well as regional markets of the genetic testing market. 2. Complete coverage of all the segments in the genetic testing market to analyze the trends, developments in the global market and forecast of market size up to 2025. 3. Comprehensive analysis of the companies operating in the global genetic testing market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company. 4. IGR- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.

For more information, please contact:

Hina Miyazu

Shibuya Data Count Email: sales@sdki.jp Tel: + 81 3 45720790

[somya08]

Global Genetic Testing Market Size, Status and Forecast 2021-2027

Genetic testing, also known as DNA testing, allows the determination of bloodlines and the genetic diagnosis of vulnerabilities to inherited diseases. In agriculture, a form of genetic testing known as progeny testing can be used to evaluate the quality of breeding stock. In population ecology, genetic testing can be used to track genetic strengths and vulnerabilities of species populations.

The demand for genetic testing is growing owing to the increasing genetic mutations in fetuses and newborns and growing prevalence of hereditary genetic disorders, and infectious diseases. In the US, a large number of infants are being born with congenital heart disease (CHD). Owing to factors such as genetic conditions, the consumption of medications or alcohol during pregnancy, or viral infection, infants are susceptible to developing CHD. Technavio?s market study identifies the growing prevalence of genetic disorders to be one of the primary growth factors for the genetic testing market. CHD may occur in infants in varying patterns such as autosomal dominant, autosomal recessive, X-linked dominant, and X-linked recessive. A key vendor manufactured Invitae Congenital Heart Disease Panel, that can analyze efficiently 42 genes that cause CHD prematurely.

Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-genetic-testing-2021-2027-31

Market Analysis and Insights: Global Genetic Testing Market

The global Genetic Testing market size is projected to reach US$ 12860 million by 2027, from US$ 6841.1 million in 2020, at a CAGR of 9.0% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Genetic Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Genetic Testing market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Genetic Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Genetic Testing market.

Global Genetic Testing Scope and Market Size

Genetic Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Genetic Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

Analyzers

Consumables

Segment by Application

Predictive and Diagnostic Testing

Prenatal, Newborn, and Pre-Implantation Testing

Pharmacogenomic Testing

Forensic, Relationship, and Ancestry Testing

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Nordic

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Abbott

bioM?rieux

Bio-Rad Laboratories

F. Hoffmann-La Roche

Myriad Genetics

QIAGEN

Quest Diagnostics

Get the Complete Report & TOC @ https://www.grandresearchstore.com/life-sciences/global-genetic-testing-2021-2027-31

Table of content

1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Genetic Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Analyzers 1.2.3 Consumables 1.3 Market by Application 1.3.1 Global Genetic Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Predictive and Diagnostic Testing 1.3.3 Prenatal, Newborn, and Pre-Implantation Testing 1.3.4 Pharmacogenomic Testing 1.3.5 Forensic, Relationship, and Ancestry Testing 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Genetic Testing Market Perspective (2016-2027) 2.2 Genetic Testing Growth Trends by Regions 2.2.1 Genetic Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Genetic Testing Historic Market Share by Regions (2016-2021) 2.2.3 Genetic Testing Forecasted Market Size by Regions (2022-2027) 2.3 Genetic Testing Industry Dynamic 2.3.1 Genetic Testing Market Trends 2.3.2 Genetic Testing Market Drivers 2.3.3 Genetic Testing Market Challenges 2.3.4 Genetic Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Genetic Testing Players by Revenue 3.1.1 Global Top Genetic Testing Players by Revenue (2016-2021) 3.1.2 Global Genetic Testing Revenue Market Share by Players (2016-2021)

If You Have Any Question Related To This Report Contact Us @ https://www.grandresearchstore.com/enquire-now/global-genetic-testing-2021-2027-31

CONTACT US: 276 5th Avenue, New York, NY 10001, United States International: +1(646)-781-7170 / +91 8087042414 Email: help@grandresearchstore.com Follow Us On linkedin :- https://www.linkedin.com/company/grand-research-store

[kritikarehani]

Down Syndrome Market Size, Share, Market Research Reports 2030

Down Syndrome (DS) is a genetic disorder caused by presence of an extra copy of chromosome 21 making a total of 47 chromosome instead of 46. The condition is associated with intellectual disability, a characteristic facial appearance, and weak muscle tone (hypotonia) in infancy.

DelveInsight's "Down Syndrome Market Insights, Epidemiology and Market Forecast-2030" report delivers an in-depth understanding of the Down Syndrome, historical and forecasted epidemiology as well as the Down Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Geography Covered

· The United States

· EU5 (Germany, France, Italy, Spain, and the United Kingdom)

· Japan

Study Period: 2017-2030

Download full report @https://www.delveinsight.com/sample-request/down-syndrome-market

Down Syndrome Disease Understanding and Treatment Algorithm

People with DS may have a variety of birth defects and among these half of them are born with heart defect. Along with these, other conditions such as digestive abnormalities, leukemia and hypertension are also common.

Patients with DS have increased risk of dementia with age having 70% chance of developing dementia after the age of 50. Physical features associated with DS include upward slanted eye, flattened facial profile and nose, short neck, small head, ear and mouth.

There are three types of DS: trisomy 21 (nondisjunction), translocation and mosaicism. 95% cases of DS are caused by Trisomy of chromosome 21.

Trisomy 21 is caused by meiotic nondisjunction or abnormal segregation of chromosomes occurring mainly during maternal oogenesis (95%), particularly at meiosis I (MI) (80%).

The DelveInsight Down Syndrome market report gives a thorough understanding of the Down Syndrome by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. 

Down Syndrome Epidemiology  

Down Syndrome (DS) is a chromosomal condition that is associated with intellectual disability, a characteristic facial appearance, and weak muscle tone (hypotonia) in infancy. All affected individuals experience cognitive delays, but the intellectual disability is usually mild to moderate.

The Down Syndrome epidemiology division provide insights about historical and current Down Syndrome patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Key Findings

· The total diagnosed prevalent population of DS in the 7MM was 545,992 in 2017 and estimated to rise at a significant rate during the study period (2017–2030).

· According to the estimates, it was found that DS is most prominent in people of age 0–9 years.

· According to DelveInsight’s analysis, type specific diagnosed prevalent cases of DS were the maximum in Trisomy 21, followed by translocation and mosaicism among all the countries in the 7MM during the study period (2017–2030).

Click here and download the epidemiology insights of the report.

Down Syndrome Drug Chapters

ACI-24 by AC immune, is a liposomal therapeutic anti-Abeta vaccine candidate, which generates antibodies specific to disease-causing conformations. The vaccine is designed to stimulate a patient's immune system to produce antibodies that specifically target the oligomeric and fibrillary Abeta proteins to prevent plaque accumulation and to enhance plaque clearance.

Pentylenetetrazole (BTD-001), is under development by Balance Therapeutics. An orally administered drug candidate which is a small molecule GABA antagonist and is in Phase I stage of clinical development for the treatment of DS.

Apart from the above mentioned molecules, there are few companies that are investigating their molecules in discovery or pre-clinical phase, those companies include, ManRos Therapeutics (DYRK1A inhibitors), NeuroNascent (NNI-351), KinoPharma (KPO1143), Avanti Biosciences (ABI-02), Aelis Farma (AEF0217), Elixirgen Therapeutics (ZSCAN4), and NeuroCircuit Therapeutics. Since all the molecules are in discovery or preclinical phase, it is not possible to predict their market during our forecasted period (2020–2030).

Drug chapter segment of the Down Syndrome report encloses the detailed analysis of Down Syndrome marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs. It also helps to understand the Down Syndrome clinical trial details, expressive pharmacological action, agreements and collaborations, approval and patent details, advantages and disadvantages of each included drug and the latest news and press releases.

Click here and download pipeline insights of the report: https://www.delveinsight.com/report-store/down-syndrome-pipeline-insight

Request for sample pages: https://www.delveinsight.com/sample-request/down-syndrome-market

Down Syndrome Market Outlook

DS is the most common genetic cause of severe learning disabilities in children associated with developmental delays, learning difficulties, health issues and some physical abnormalities.

The current treatment targets symptoms but doesn’t target the underlying mechanisms causing the deficits. The treatment includes speech therapy, physical therapy, occupational therapy and special education. Drug therapy is not currently a component of standard care for DS.

DS occurs due to chromosomal abnormalities. Being a genetic disorder, individuals affected with DS shows diverse symptoms. Therefore, a single approach or innovation cannot solve the purpose for different individuals with altered and varied needs. Thus, the market demands the emergence of products catering different needs.

Life expectancy of individuals with DS has increased due to improvements in health care and decreased infant mortality and most importantly better non-invasive prenatal screening tests made available in the recent years. The life expectancy of an individual with DS tends to be in the 60’s. Persons with DS may be predisposed to certain illnesses and medical conditions, but that genetic arrangement does not guarantee their development.

Thus, considering the current unmet needs, many companies are investing in the development of appropriate therapies for the treatment of DS. However, many of the recent clinical trials are poorly controlled and no controlled clinical studies for DS have demonstrated their good safety and efficacy.

Also, with the rise in prenatal screening tests across US, the number of babies born with DS has significantly decreased.

Many studies of drugs to treat symptoms of dementia in DS have included only a few participants. The results of these studies have not shown clear benefits of these drugs, either. Similarly, studies of antioxidants for dementia in DS have shown that these supplements are safe, but not effective.

The Down Syndrome market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Down Syndrome market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 

Key Findings

• Many companies are exploring various drugs to find an efficient therapy for the treatment of DS, including NeuroNascent (NNI-351), ManRos (DYRK1A inhibitors), AC Immune Therapeutics (ACI-24), and Balance Therapeutics (BTD-001), however some drugs lag behind either due to lack of efficacy and safety concerns, some are discontinued or some are in the very early stage of development process, thus market size estimation of these drugs at this stage is very early to predict.

Download market insights of the report: https://www.delveinsight.com/report-store/down-syndrome-market

Download sample pages of the report: https://www.delveinsight.com/sample-request/down-syndrome-market

[dpiresearchofficial]

Global Non-Invasive Prenatal Testing(NIPT) market is anticipated to grow over US$ 2.5 Billion by 2025 with an impressive double-digit growth rate in the forecast period 2018 – 2025.

The market is driven by the number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards childbearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non-invasive techniques over invasive methods.

“Global Non-Invasive Prenatal Testing Market: Demand, Insights, Analysis, Opportunities, Growth Potential and Forecast 2018 – 2025” presents an in-depth assessment of the Global Non-Invasive Prenatal Testing (NIPT) market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for Global Non-Invasive Prenatal Testing (NIPT). The research includes historic data from 2014 to 2017 and forecasts until 2025.

The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on the market share of NIPT tests and Countries-based market. The report also includes an assessment of comparative test analysis by companies. Additionally, the report includes insights into the Global perspectives on clinical adoption of NIPT. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution, and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Global Non-Invasive Prenatal Testing (NIPT) market.

The report concludes with the profiles of major players in the Global Non-Invasive Prenatal Testing (NIPT) market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios, and the latest development and trends of the Non-Invasive Prenatal Testing (NIPT) market.

KEY FINDINGS:

United States is anticipated to be the most attractive market in the Global Non-Invasive Prenatal Testing(NIPT) market

China NIPT test market is set to cross USD 400 Million by 2025

Panorama test accounted for the highest share in Global Non-Invasive Prenatal Testing(NIPT) market

Verifi test has the second highest revenue share in the Global Non-Invasive Prenatal Testing(NIPT) market

Rising focus on Reimbursement for NIPT test will revolutionize the market

Two–Child policy is likely to boost China NIPT market

The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:

Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics

Major and Promising Non-Invasive Prenatal Testing (NIPT) Covered Under This Report are:

Panorama, MaterniT21 PLUS, Harmony, Verifi, NIFTY, IONA, PrenaTest, Bambni, Veracity and Other Tests

Major Countries Analyzed Under This Report are:

United States, China, Japan, India, Brazil, Australia, New Zealand, United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark and Rest of the Countries.

The Latest Industry Data Included in this Report:

Global Non–Invasive Prenatal Testing Market Volume & Future Trends (2014 – 2025)

Global Non–Invasive Prenatal Testing Market Revenue & Future Trends (2014 – 2025)

Global Non–Invasive Prenatal Testing Market Share and Y–o–Y Growth (%)

Market Share Analysis, by Test, 2014 – 2025 (%)

Market Share Analysis, by Major Countries, 2014 – 2025 (%)

Global Non–Invasive Prenatal Testing Market, By Test (Volume and Value),2011 – 2025

Global Non–Invasive Prenatal Testing Market, By Geography (Volume and Value),2014 – 2025

Non–Invasive Prenatal Testing(NIPT) Comparative Analysis – By Test

Major Deals in Global Non–Invasive Prenatal Testing Market

Global Perspectives on Clinical Adoption of NIPT

Global Non–Invasive Prenatal Testing Market Drivers and Inhibitors

Key Companies Analysis

[solutionsandservices]

Global Prenatal and New-born Genetic Testing Industry 2019 Market Research Report Key Trends, Size, Shares, Forecast and Opportunities Prenatal and New-born Genetic Testing Market Report The report offers an overview of the Prenatal and New-born Genetic Testing with the help of application segments and geographical regions (United States, Europe, China, Japan, Southeast Asia, India, Central & South America, ROW) that govern the market currently.

[factmrresearchreports]

Opportunities in Genetic Testing Services Market Abound amid COVID-19, Concludes Fact.MR

The global Genetic Testing Services growth report offers complete overview of various aspects. The report includes the major market conditions across the globe such as the product profit, price, production, capacity, demand, supply, as well as market growth structure. In addition, this report offers significant data through the SWOT analysis and Porter’s five forces investment return data, and investment feasibility analysis. The Global Genetic Testing Services growth study is major compilation of significant information with respect to the competitor details of this market. According to a new Fact.MR study, the Genetic Testing Services growth is poised to expand at an impressive value CAGR of 7.6% through 2026.

Note: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

Our best analysts have surveyed the market report with the reference of inventories and data given by the key players:

Quest     Diagnostics Incorporated

Genomic     Health, Inc.

NeoGenomics     Laboratories, Inc.

Eurofins     Scientific

The Global Genetic Testing Services growth report covers deep insights of various vital aspects of the market. Report of Genetic Testing Services provides the summarized study of several factors encouraging the growth of the market such as manufacturers, market size, types, applications, and regions. Likewise, to assess the market size, this study offers a precise analysis of the provider’s landscape as well as a corresponding detailed study about the manufacturers operating in the Genetic Testing Services market. Moreover, in past few years owing to the new innovations and strategic ideas the Genetic Testing Services market has recorded a significant development and is anticipated to further rise over the forecast period. Likewise, the information is also inclusive of the several regions where the global Genetic Testing Services market has successfully gained the position.

The Genetic Testing Services growth report offers an in depth analysis about the cost structure, market size and PESTEL analysis which offers market outlook. Likewise, the global Genetic Testing Services market report focuses on the major economies across the globe. Geographically, the Genetic Testing Services market report covers the key regions and countries along with their revenue analysis. Using the report, consumer can identify several key dynamics of the market that holds an effective impact and govern. Moreover, the report is describing several types of Genetic Testing Services market. Likewise, this report includes primary and secondary drivers, leading segments, market share, drivers, and the geographical landscape of the Genetic Testing Services market. This study offers a separate analysis of the major trends in the existing market, mandates and regulations, micro & macroeconomic indicators is also comprised in the global Genetic Testing Services market report. By doing so, the study estimated the attractiveness of every major segment during the prediction period.

Global Genetic Testing Services Market Split by Product Type and Applications:

On the basis of Product types,

Prenatal     Testing

New Born     Screening

Predictive     and Presymptomatic Testing

Pharmacogenomic     Testing

On the basis of End-user,

Oncology

Infectious     Diseases

Autoimmune     Diseases

Geographically, the detailed analysis of consumption, revenue, Genetic Testing Services market share and growth rate, historic and forecast of the following regions are covered- 

·         North America

·         Latin America

·         Europe

·         Japan

·         APEJ

·         MEA

The research report of global Genetic Testing Services market comprises significant insights for the clients and vendors that are looking to maintain their market position as well as to expand the business in current and upcoming market scenario. Furthermore, the report provides the detailed study of the facts and figures, as viewer search for the scope in market growth related to the category of the product.

[nickyshukla1]

Global NON‚ÄÌINVASIVE PRENATAL TESTING Market - Global Demand, Sales, Consumption and Forecasts 2018-2025

Summary - A new market study, titled “Global NON‚ÄÌINVASIVE PRENATAL TESTING Market Analysis, Trends and Opportunities 2018-2025” has been featured on WiseGuyReports

 Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025. The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods. “Europe Non–Invasive Prenatal Testing Market Research Report 2018” presents an in–depth assessment of the Europe non–invasive prenatal testing market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the market situation and future outlook. The research includes historic data from 2014 to 2017 and forecasts until 2025. The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, NIPT test volume, revenues and provides forecasts through 2025. A comprehensive analysis has been done on market share of country–based market. The report also includes assessment of comparative test analysis by companies. Key trends in terms of collaboration, partnership, merger & acquisition, venture capital investment, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the Europe non–invasive prenatal testing market.

 ALSO READ: http://heraldkeeper.com/news/europe-non-invasive-prenatal-testing-market-covid-19-impact-on-industry-analysis-size-share-growth-trends-forecasts-2025-506062.html

 The superior geographic segments are identified in the report which studies NIPT test consumed and market revenue of the 15 countries. The countries included in this report are United Kingdom, Germany, Italy, Spain, France, Switzerland, Sweden, Belgium, Russia, Turkey, Netherland, Poland, Armenia, Moldova, Denmark from 2014 to 2017 and forecasts to 2025. The report concludes with the profiles of major players in the Europe non–invasive prenatal testing market. The key market players are evaluated on various parameters such as company overview, NIPT test portfolios and latest development and trends of the non–invasive prenatal testing market. The major European companies dominating this market for its products, services and continuous product developments are: Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics Major and Promising NIPT Test Available in the European Region are: • Panorama • MaterniT21 PLUS • Harmony • Verifi • NIFTY • IONA • PrenaTest • Veracity

 FOR MORE DETAILS: https://www.wiseguyreports.com/reports/3449812-europe-non-invasive-prenatal-testing-market-research-report-2018

 About Us:

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Contact Us:

NORAH TRENT                                                      

sales@wiseguyreports.com       

Ph: +162-825-80070 (US)                          

Ph: +44 203 500 2763 (UK)      

[marketreasearch]

Global Hereditary Testing Market to Witness a Pronounce Growth During 2027

Hereditary testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to hereditary testing market.

Market Analysis and Insights: Global Hereditary Testing Market

Hereditary testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account toUSD 9.31 billion by 2027 growing at a CAGR of 6.10% in the above-mentioned forecast period. The accelerating generative hereditary health scope is one of the key market drivers.

The major players covered in the hereditary testing marketreport are F. Hoffmann-La Roche Ltd, Abbott, Amgen Inc., ELITechGroup, GW Pharmaceuticals plc, Thermo Fisher Scientific Inc., Pfizer Inc., PerkinElmer Inc., AutoGenomics, Bio-Rad Laboratories, Inc., BioMarin, Sarepta Therapeutics,Amicus Therapeutics, Inc., Alexion Pharmaceuticals, Inc., Sanofi, Takeda Pharmaceutical Company Limited, Vertex Pharmaceuticals Incorporated,among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa(MEA) and South America separately. DBMR analystsunderstand competitive strengths and provide competitive analysis for each competitor separately.

Get Sample Report + All Related Graphs & Charts @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-hereditary-testing-market

The harmonious upsurge in trade for new-born screening has pointed to an improvement in the commerce of DNA experiment equipment. Progressing keen-sightedness of new-born screening crosswise the earth is moreover supporting in earnings growth. Reformations in genetic experimentation guidelines beget headed to the formation of a multigene board trial for genetic melanoma into clinical application. Continuous advancements in the distribution model are expected to profit the genetic examination business. Technological amendments are performing a significant function in the market growth by enhancing their delivery assistance and progressing the effectiveness of the technology implied. Organizations are adopting a cloud-based administration design to compose bioinformatics technology accessible for employment by other labs. Expense and preservation solicitudes encountered by users of the analysis and the dearth of adequate supervision of the experiments can act as a restraint for the market.

This hereditary testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Data Bridge Market Research hereditary testing market contact us for an Analyst Brief,our team will help you take an informed market decision to achieve market growth.

Grab Your Report at an Impressive 30% Discount! Please click Here @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-hereditary-testing-market

Global Hereditary Testing Market Scope and Market Size

Hereditary testing marketis segmented onthe basis of hereditary cancer testing and hereditary non-cancer testing. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Based onhereditary cancer testing, the hereditary testing marketis segmented into lung cancer, breast cancer, colorectal cancer, cervical cancer, ovarian cancer, prostate cancer, stomach/gastric cancer, melanoma, sarcoma, uterine cancer, pancreatic cancer, and others.

Based on hereditary non-cancer testing, the hereditary testing market is segmented intogenetic tests, newborn genetic screening, preimplantation genetic diagnosis & screening, non-invasive prenatal testing (NIPT) & carrier screening tests. Genetic tests are further sub-segmented into cardiac diseases, rare diseases, and other diseases.

Hereditary Testing Market Country Level Analysis

Hereditary testing marketis analysed and market size insights and trends are provided by country,hereditary cancer testing and hereditary non-cancer testing as referenced above.

The countries covered in the hereditary testing marketreport are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the hereditary testing market due to the high prevalence of breast cancer patients, and entrance of the key market players and strong healthcare foundation.

The country section of the hereditary testing marketreport also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

For More Insights Get Detailed TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-hereditary-testing-market

Healthcare Infrastructure growth Installed base and New Technology Penetration

Hereditary testing marketalso provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for hereditary testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the hereditary testing market. The data is available for historic period 2010 to 2018.

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today! Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @ Corporatesales@databridgemarketresearch.com

[newinnovationalmarketresearch]

DNA Testing/Diagnostics Market Research (2020-2025) Report by Global Size, Share, Trends, Type, Application

DNA Testing/Diagnostics Market Research Report (2020-2025) Provides In-Depth Analysis by Scope, Growth Rate, Driving Factors, Competitive Situation, Top Manufacturers and Upcoming Trends. DNA Testing/Diagnostics Market report split global into several key Regions which mainly includes Market Overview, Table of Content, List of Figures and Applications. DNA Testing/Diagnostics Market Growing at Higher CAGR Rate of XX% between (2020-2025).

 Summery:-

 The global DNA Testing/Diagnostics Market is anticipated to grow at a staggering CAGR in the forthcoming period. Diagnostic tests are the basis of a successful healthcare system that enables vital information about patients and healthcare providers necessary to land into right decisions.

 Request a Sample PDF Copy of This Report @ https://www.millioninsights.com/industry-reports/dna-testing-diagnostics-market/request-sample

 The key driving factors responsible for the growth of DNA Testing/Diagnostics market :

 The drivers for DNA testing market include demand for personalized medicine applications for chronic disorders is likely to propel the market growth. Rise in demand for DNA diagnostics for new born babies adds to the market growth during the forecast period. In addition, genetic testing gains a higher traction to determine patient’s health at different stages of disease development fuels the market growth.

 Product segment for DNA testing/diagnostics industry includes service & software, reagents and instruments. By technology, the DNA diagnostics market comprises in-situ hybridization, microarray, PCR, mass spectrometry and sequencing technology. Application segment for DNA testing industry include myogenic disorder and infectious disease. Infectious disease is segmented as Hepatitis B virus, Hepatitis C virus, TB, CT/NG. MRSA and HPV.

 Myogenic disorder is further segmented as pre-implantation diagnostics and prenatal diagnostics. Geographical segmentation for DNA testing market includes North America, South America, Europe, Asia-Pacific, Middle East and Africa. North America holds a dominant share in the global market owing to rise in adoption of DNA diagnostics technology and significant prevalence of chronic and infectious disease.

 Asia-Pacific market is anticipated to rise at a higher CAGR due to rise in research programs conducted by government in developing economies. Constant R&D and commercialization of technology for treatment of chronic diseases is likely to contribute to the market growth during the forecast period. The key players in the DNA diagnostics industry include Cephide Inc., 454 Life Sciences, Abbott Laboratories, Beckman Coulter Inc., Bio-Rad Laboratories, Hologic, GE Healthcare, Thermo Fisher Scientific, Illumina Inc., TransgenomicInc., Siemens Healthcare, Roche Diagnostics, Qiagen, Illumina, AlereInc, Affymetrix Inc., Agilent Technologies Inc., Dako, and Applied Biosystems Group.

 View Full Table of Contents of This Report @ https://www.millioninsights.com/industry-reports/dna-testing-diagnostics-market

 Table of Contents:-

 •         DNA Testing/Diagnostics Market Overview

•         DNA Testing/Diagnostics Market Competition by Manufacturers

•         DNA Testing/Diagnostics Market Production, Revenue (Value) by Region (2014-2025)

•         DNA Testing/Diagnostics Market Supply (Production), Consumption, Export, Import by Regions (2014-2025)

•         DNA Testing/Diagnostics Market Production, Revenue (Value), Price Trend by Type

•         DNA Testing/Diagnostics Market Analysis by Application

•         DNA Testing/Diagnostics Market Manufacturers Profiles/Analysis

•         DNA Testing/Diagnostics Market Manufacturing Cost Analysis

•         DNA Testing/Diagnostics Market Industrial Chain, Sourcing Strategy and Downstream Buyers

•         DNA Testing/Diagnostics Market Marketing Strategy Analysis, Distributors/Traders

•         DNA Testing/Diagnostics Market Effect Factors Analysis

•         DNA Testing/Diagnostics Market Research Findings and Conclusion

Get in touch

At Million Insights, we work with the aim to reach the highest levels of customer satisfaction. Our representatives strive to understand diverse client requirements and cater to the same with the most innovative and functional solutions.

 Contact Person:

Ryan Manuel

Research Support Specialist, USA

Email: ryan@millioninsights.com

 Million Insights

Office No. 302, 3rd Floor, Manikchand Galleria,

Model Colony, Shivaji Nagar, Pune, MH, 411016 India

tel: 91-20-65300184

Email: sales@millioninsights.com